Aesica Pharmaceuticals

Cover Image

Aesica Pharmaceuticals

Aesica Pharmaceuticals

190 Follower

>1.000 Mitarbeitende

Neuigkeiten

Aesica Pharmaceuticals
Aesica Pharmaceuticalshat einen Beitrag geschrieben.3. Juni 2016
Our Italian colleagues are attending the AFI 56 Symposium conference in Rimini in June. Attending? Why not schedule a meeting with one of our experts to see how we can simplify your supply chain by offering you a tried and trusted single source CDMO for both APIs and finished dosage forms - getting you to market sooner, more cost-effectively and with reduced risk.
Aesica Pharmaceuticals
Aesica Pharmaceuticalshat einen Beitrag geschrieben.9. Oktober 2014
Aesica customers benefit from shortened drug development times, drug development efficiency improvements and vast reductions in the amount of API required for development Aesica, the global contract development and manufacturing organisation (CDMO), today highlights that it is the only CDMO that is bringing the multiple benefits of continuous tablet processing technology to its customers. The company is the first CDMO to install the technology in collaboration with its customer and to provide...
Aesica Pharmaceuticals
Aesica Pharmaceuticalshat einen Beitrag geschrieben.8. Oktober 2014
Aesica, the global contract development and manufacturing organisation (CDMO), provides a full high potency drug substance and drug manufacturing service, covering the production of highly potent Active Pharmaceutical Ingredients (HPAPIs) and the manufacturing of drug products with the established capabilities in place to handle drug development right through to full scale commercial product supply. The exponential rate of growth in the market for highly potent therapeutics has caused si...
Aesica Pharmaceuticals
Aesica Pharmaceuticalshat einen Beitrag geschrieben.7. Oktober 2014
Aesica, the global contract development and manufacturing organisation (CDMO), provides a full service controlled drugs service, covering the production of Active Pharmaceutical Ingredients (APIs) and the manufacturing of drug products with advanced, well established capabilities in place to handle drug development right through to full scale commercial product supply. The huge growth in demand for controlled or scheduled drugs has led to major manufacturing challenges from API scale up, clin...
Aesica Pharmaceuticals
Aesica Pharmaceuticalshat einen Beitrag geschrieben.18. September 2014
Aesica, an international pharmaceutical company, has announced a number of new opportunities at its Nottingham site in the UK. With a continued focus on pharmaceutical contract development services, Nottingham is an integral part of Aesica’s strategy to drive further growth in the contract development and manufacturing industry. Both locally and internationally, Aesica has experienced significant growth and is now looking to welcome new employees into the company as it continues to flourish. ...
Aesica Pharmaceuticals
Aesica Pharmaceuticalshat einen Beitrag geschrieben.1. September 2014
Aesica today celebrates the company’s 10th anniversary. Formed in 2004, the company has transitioned from an active pharmaceutical ingredient (API) manufacturer to a full service CDMO, offering API development and manufacturing, formulation development and clinical trial supply through to finished dose manufacturing and packaging, supporting many of the top twenty pharmaceutical companies across the globe. read more.. http://tinyurl.com/kmp2xod
Aesica Pharmaceuticals
Aesica Pharmaceuticalshat einen Beitrag geschrieben.27. August 2014
Aesica, the global contract development and manufacturing organisation (CDMO), is pleased to announce the 20th anniversary of its site located at Zwickau in Germany. The facility possesses multiple solid oral dosage form technologies and service capabilities and has been integral in fast establishing Aesica as a leading provider of encapsulation services. The immediate and controlled release technology enables Aesica to work with powders, pellets and tablets into capsules. The company has inv...
Aesica Pharmaceuticals
Aesica Pharmaceuticalshat einen Beitrag geschrieben.27. August 2014
Aesica Pharmaceuticals, the global pharmaceutical contract development and manufacturing organisation (CDMO), is adding additional services in its oral solids capability including a new roller compaction unit for dry granulation production in Zwickau, Germany after identifying this area as a key growth market within the domestic market. The company is committed to capitalising on the presence of its German sites (Monheim and Zwickau), having identified the German pharma economy as a growth ar...
Aesica Pharmaceuticals
Aesica Pharmaceuticalshat einen Beitrag geschrieben.27. August 2014
Aesica, the global contract development and manufacturing organisation (CDMO), has today announced the appointment of Nadine K. Reuter to the position of Business Development Manager, Finished Dose with responsibility for assisting in the drive to expand revenues from contract manufacturing activities across Germany, Austria and Switzerland. The new role encompasses growing new business, both by working closely with existing customers and through the development of new customer relationships, in...

XING empfiehlt folgende Unternehmen:

Aesica is a leading pharmaceutical contract development and manufacturing organisation (CDMO) for both APIs and finished dose forms.Our full service, end-to-end pharmaceutical development and manufacturing solution comprises capabilities in formulation development for API and finished dose, manufacturing at all scales and...

Alle Infos ansehen

Ähnliche Jobs

Standort

Größere Karte

Newcastle upon Tyne

Q5 Qorum Business Park HQ, NE12 8BS Newcastle upon Tyne, Vereinigtes Königreich